1. Home
  2. VVOS vs REVB Comparison

VVOS vs REVB Comparison

Compare VVOS & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.18

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.00

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
REVB
Founded
2016
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
3.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
VVOS
REVB
Price
$0.18
$1.00
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
14.3M
35.9K
Earning Date
04-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
72.68
EPS
N/A
N/A
Revenue
$17,443,000.00
N/A
Revenue This Year
$69.66
N/A
Revenue Next Year
$48.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.16
$0.47
52 Week High
$3.70
$2.32

Technical Indicators

Market Signals
Indicator
VVOS
REVB
Relative Strength Index (RSI) 31.62 44.17
Support Level $0.16 $0.94
Resistance Level $0.55 $1.21
Average True Range (ATR) 0.04 0.06
MACD -0.00 -0.00
Stochastic Oscillator 8.21 42.57

Price Performance

Historical Comparison
VVOS
REVB

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: